Xuxiao Ye

8PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 18, 2026
Use of Negative Control Outcomes to Assess Cohort Comparability Among Evolocumab Initiators: A Real-World Database Study.

|Dec 12, 2024
Lipid-lowering agent preferences among patients with hypercholesterolemia: a focus group study.

Hei Hang Edmund Yiu, Kehui Deng, Lydia Wy Fung

|Jul 19, 2024
Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis.

Wei Kang, Kuan Peng, Vincent K C Yan

|Apr 29, 2023
BNT162b2 or CoronaVac Vaccinations Are Associated With a Lower Risk of Myocardial Infarction and Stroke After SARS-CoV-2 Infection Among Patients With Cardiovascular Disease.

Xuxiao Ye, Vincent K C Yan, Hei Hang Edmund Yiu

|Oct 14, 2022
Effectiveness of Simvastatin Versus Gemfibrozil for Primary Prevention of Cardiovascular Events: A Retrospective Cohort Study of 223,699 Primary Care Patients.

Joseph E Blais, Xuxiao Ye, Eric Y F Wan

|Aug 18, 2022
Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study.

Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye

Pageof 2

Frequent Collaborators

7 joint publications

Esther Wai Yin Chan

6 joint publications

Ian Chi Kei Wong

5 joint publications

Vincent Ka Chun Yan

5 joint publications

Xue Li